Sector Chart BLS Pharmaceuticals Limited

Stocks

BLS

AU0000477796

Biotechnology & Medical Research

Market Closed - Australian S.E. 10:10:15 19/08/2026 +04			5-day change	1st Jan Change
0.9400 ^AUD	+1.08%		+1.08%	+123.81%

07-27	BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range	MT
06-03	Bioxyne Limited Announces Appointment of Edward Myer as Independent Non-Executive Director and Independent Chair of Audit and Finance Committee	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
BLS PHARMACEUTICALS LIMITED	152M	-	-	-	-	-
LONZA GROUP AG	48.63B
REVOLUTION MEDICINES, INC.	46.3B	-	-	-	-	-
BEONE MEDICINES AG	41.97B
IQVIA HOLDINGS INC.	39.51B
CELLTRION, INC.	31.75B